HomeOCX • NASDAQ
OncoCyte Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.49M | 373.25% |
Operating expense | 6.04M | 21.70% |
Net income | -33.51M | -109.55% |
Net profit margin | -2.26K | 55.72% |
Earnings per share | — | — |
EBITDA | -4.86M | -2.68% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.64M | -8.44% |
Total assets | 35.08M | -53.16% |
Total liabilities | 47.36M | -3.94% |
Total equity | -12.27M | — |
Shares outstanding | 28.60M | — |
Price to book | -4.54 | — |
Return on assets | -25.75% | — |
Return on capital | -532.50% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -33.51M | -109.55% |
Cash from operations | -5.35M | -21.02% |
Cash from investing | -210.00K | -303.88% |
Cash from financing | 10.84M | 36,223.33% |
Net change in cash | 5.27M | 221.19% |
Free cash flow | -6.03M | -207.29% |
Previous close
$3.18
Day range
$3.16 - $3.29
Year range
$1.92 - $4.75
Market cap
92.09M USD
Avg Volume
107.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
48
